Default company panoramic image
41c697a5 342f 4690 9fba 3aba32c6adfd

Cascade Prodrug Inc

We have a lead compound in preclinical trials which in tumor models shows significant improvement in safety and efficacy using the tumors own microenvironment

  • Stage Product In Development
  • Industry Biotechnology
  • Location Eugene, OR, USA
  • Currency USD
  • Founded September 2009
  • Employees 0
  • Incorporation Type C-corp
  • Website cascadeprodrug.com

Company Summary

Cascade Prodrug Inc is in preclinical development of a novel drug utilizing it's proprietary technology platform. This compound is a prodrug derivative of blockbuster FDA approved agent to treat cancer. Data suggests this new form has the potential for significant improvement to the theraputic index of the parent. Our commercial strategy is to modify these parent drugs, create new prodrugs, then license/exit with a major pharmaceutical company.

Team

Advisors

  • Default avatar
    Ernie Bootsma, Ater Wynne
    Lawyer
    Unconfirmed
    Default avatar
    Peter Buss KS&Co
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Oregon Angel Fund
    Unconfirmed
    Default avatar
    Willamette Angel Fund
    Unconfirmed
    Default avatar
    Private Side Investors
    Unconfirmed